SRTS
Sensus Healthcare, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $6.39 | $3.47 | -46% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q1 2026 | Q2 2026 | → $3.61 | -6% |
| Two Sigma Investments | Q3 2024 | Q1 2026 | → $3.83 | -38% |
| Millennium Management | Q3 2024 | Q2 2025 | → $4.66 | -25% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Sensus Healthcare, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 12, 2026 — the most recent Form 4 on file — not from today.
- Form 40002097345-26-000008May 12, 2026
- Form 4/Aamend0002097345-26-000006Apr 23, 2026
- Form 4/Aamend0001800068-26-000003Apr 22, 2026
- Form 4/Aamend0001960987-26-000004Apr 22, 2026
- Form 40002097345-26-000004Feb 26, 2026
- Form 40001720602-25-000015Dec 16, 2025
- Form 4/Aamend0001720602-25-000013Dec 16, 2025
- Form 40002097345-25-000008Nov 21, 2025
- Form 40002097345-25-000006Nov 20, 2025
- Form 40001300111-25-000005Nov 19, 2025
- Form 40001720602-25-000011Nov 19, 2025
- Form 4/Aamend0001720602-25-000010Nov 18, 2025
- Form 4/Aamend0001720602-25-000007Nov 13, 2025
- Form 40001720602-25-000004Nov 12, 2025
- Form 40001415889-25-021748Aug 14, 2025
Fundamentals
XBRL · Sensus Healthcare, Inc.Annual figures sourced directly from Sensus Healthcare, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Sensus Healthcare, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 5, 2026
- 8-KMaterial eventJun 2, 2026
- 10-QQuarterly reportMay 13, 2026
- 8-KMaterial eventMay 7, 2026
- DEF 14AProxy statementApr 29, 2026
- 10-KAnnual reportMar 4, 2026
- 8-KMaterial eventFeb 12, 2026
- 8-KMaterial eventJan 20, 2026
- 8-KMaterial eventJan 12, 2026
- 8-KMaterial eventNov 13, 2025
- 10-QQuarterly reportNov 12, 2025
- 8-KMaterial eventNov 6, 2025
- 10-QQuarterly reportAug 12, 2025
- 8-KMaterial eventAug 7, 2025
- 8-KMaterial eventJun 2, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | $3.83 | $3.61 | -6% |
| Citadel Advisors | Q3 2024 | Q2 2025 | $6.18 | $4.66 | -25% |
| Two Sigma Investments | Q3 2024 | Q1 2026 | $6.18 | $3.83 | -38% |
| Millennium Management | Q3 2024 | Q2 2025 | $6.18 | $4.66 | -25% |
| Renaissance Technologies | Q3 2024 | open | $6.39 | $3.47 | -46% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.